trial,pubID,pseudogroup,weeks,weeks,IgD-/IgM-/IgG+/Antigen++ B cells
G003,G003-210,G003,16,16,128869.0
G003,G003-434,G003,16,16,62651.0
G003,G003-291,G003,16,16,95371.0
G003,G003-622,G003,16,16,22044.0
G003,G003-516,G003,16,16,16607.0
G003,G003-799,G003,16,16,26493.0
G003,G003-135,G003,16,16,14071.0
G003,G003-732,G003,16,16,35070.0
G003,G003-710,G003,16,16,17908.0
G003,G003-630,G003,16,16,4022.0
G003,G003-396,G003,16,16,2517.0
G003,G003-611,G003,16,16,5761.0
G003,G003-550,G003,16,16,2315.0
G003,G003-753,G003,16,16,2714.0
G003,G003-138,G003,16,16,3127.0
G003,G003-243,G003,16,16,1456.0
G003,G003-831,G003,16,16,601.0
